Holy Akwar | Science Advisor, Veterinary & AMR
International Centre for Antimicrobial Resistance Solutions (ICARS)
Dr. Akwar is the Science Advisor for Veterinary Sciences and AMR at the International Centre for Antimicrobial Resistance Solutions (ICARS). He leads the development and implementation of technical initiatives designed to generate evidence on AMR mitigation and enhance preventive health strategies in animal and environmental sectors and across the One Health spectrum. He has worked with the Canadian government, Global Center for Health Diplomacy and Inclusion, International Vaccine Institute, Food and Agriculture Organization and World Organization for Animal Health, and contributed to surveillance systems, capacity building, and cross-sectoral approaches to health threats. He is a veterinary epidemiologist and One Health specialist with expertise spanning infectious diseases, vaccines, zoonoses, sustainable solutions to AMR mitigation, and health systems strengthening within a One Health framework with a focus on low- and middle-income countries. He holds a DVM degree from Ahmadu Bello University, and a PhD in epidemiology from the University of Guelph, Canada.
Appearances:
Pre-Congress Workshops - Monday 30th March @ 10:00
ANTIMICROBIAL RESISTANCE WORKSHOP
Workshop Chair: Dr Christian Harding, CSO and Co-Founder, Omniose
- 10.00 Chair’s Opening Remarks
- 10:10 Keynote Intro – Impact of Vaccines on AMR
- 10.30 Advancing Immunity: Clinical Development of a Peptide Conjugate Vaccine for Group A Streptococcus
- 10.45 Leveraging Serological Insights to Combat Emerging Pathogens and Antimicrobial Resistance
- 11.00 The Cost of Inaction: Quantifying the Economic Value of Vaccines in the Fight Against AMR
- 11.15 Two Targets, One Construct: Psl-PcrV Bioconjugate Vaccine to Tame P. aeruginosa
- 11.30 AMR, Biodefence and National Security: They’re All Connected
- 12:00 Mitigating AMR in LMICs: The Role of Vaccines in a One Health World
- 12.15 Panel Discussion: Perceptions of AMR Vaccine Development in the Current Global Climate
- 14:00 – 15:00 Funding Pipeline Updates
- 14:00 Gates Foundation
- 14:20 Wellcome Trust
- 14:40 Adjuvant Capital
- 15:00- 16:00 AMR Vaccines Development Updates
- 15:00 Applying HIV vaccine design principles to Shigella & Acinetobacter
- 15:15 Universal Pneumococcal Vaccine Development
- 15:30 From Immunity to Impact: Building Executable Vaccines Against Klebsiella pneumoniae
- 15:45 Advancing a multivalent vaccine candidate to prevent S.aureus skin infections
- 16:00 Panel: Are Combination Vaccines the Way Forward for AMR /Defining the Value of Combo Vaccines?
- Economic valuation of vaccines with reduction on AMR
- Improving coverage of viral vaccines which reduce AMR
- Explore the concept of Syndromic vaccines
Day 2 - Wednesday 1st April @ 09:10
Panel: One Health Strategies for Smarter Disease Prevention and Control
- Where can improved coordination between animal and human health sectors accelerate vaccine development and delivery?- In what ways can cross-sector collaboration unlock better use of existing tools — vaccines, diagnostics, digital platforms, and cold chain infrastructure?- How do we fund prevention when benefits are shared, but budgets and responsibilities remain siloed?
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events